Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

myRocky vs WellMedRx

myRocky
Graded #487

Lower grade

vs+3.1000000000000014
WellMedRx
Graded #456

Higher grade

The verdict

WellMedRx takes it — 54.5/100 to 51.4/100.

WellMedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WellMedRx is a multi-product compounded telehealth platform pairing GLP-1 weight-loss care with TRT, hair-loss, and sexual-health programs under one account.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWellMedRx +11
34
45
Dose & formulationmyRocky +13
53
40
Clinical oversightWellMedRx +9
64
73
Labs & monitoringWellMedRx +8
52
60
FulfillmentmyRocky +10
70
60
Contract termsWellMedRx +14
41
55
myRocky · left barWellMedRx · right bar

The numbers

MetricmyRockyWellMedRx
WeighScore51.4/10054.5/100
GradeCC
Scorecard rank#487#456
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)
WellMedRx

Graded #456 · C

Strengths

  • Named licensed pharmacy partner (Mycelium Pharmacy)
  • Clinical care delivered through OpenLoop Health, an established clinician network
  • Multi-product platform — one account covers weight loss, TRT, hair, and sexual health
  • HIPAA-compliant badge on the home page

Where it loses points

  • Monthly pricing not shown until after intake
  • State coverage not disclosed — only 'a licensed professional in your state'
  • No LegitScript registration visible on the home page
  • No NABP .pharmacy seal
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard